Form 4 for ABT Abbott Laboratories

Accepted 2026-04-28 19:37:56 ET · period of report 2026-04-24 · accession 0000902132-26-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-04-28 19:37	2026-04-24	ABT	STARKS DANIEL J	Dir	A - Grant	$0.00	+2,286	6.74M	+0.0%	$0
D	2026-04-28 19:37	2026-04-27	ABT	STARKS DANIEL J	Dir	P - Purchase	$92.65	+10.0K	6.75M	+0.1%	+$926.5K
D	2026-04-28 19:37	2026-04-24	ABT	STARKS DANIEL J	Dir	A - Grant	$0.00	+7,105	7,105	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common shares without par value	2026-04-24	A	A	2,286	$0.00	6,741,103	D	—	—	(F1) Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
2	Common	Common shares without par value	2026-04-27	P	A	10,000	$92.65	6,751,103	D	—	—	(F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.43 to $93.04, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3	Derivative	Option (right to buy)	2026-04-24	A	A	7,105	$0.00	7,105	D	$91.86 · 2026-04-24 to 2036-04-23	7,105 Common Shares	(F4) Stock option granted under the Program, in a transaction exempt from Section 16 under Rule 16b-3.